Literature DB >> 2452789

Stochastic humoral expression of human growth hormone epitopes.

M Etcheverrigaray1, A C Paladini, L A Retegui.   

Abstract

Competition experiments between insolubilized monoclonal antibodies (mAb) and polyclonal antisera has led to the description of the humoral expression of human growth hormone (hGH) epitopes. This study was carried out with sera from mice and hamsters submitted to different immunization schedules: chronic administration of the antigen, secondary response and conventional hyperimmunization. The results indicated the absence of a unique immunodominant epitope in hGH; a significant individual variation of antibody (Ab) population titres with time; changes with time in the relative proportion of one Ab population with respect to the others; and the occurrence of Ab enhancing the 125I-hGH binding to five mAb depending upon the individuals and the time of immunization. Heterocliticity towards non-human GH was also detected. Although most of the animals showed cross-reacting Ab, two out of 12 mice, chronically injected, developed heteroclitic Ab. The data suggest that the humoral response to different epitopes of a protein antigen during the maturation of the immune response is a stochastic process leading to transient humoral immunodominance, enhancing Ab populations and heterocliticity, depending upon individual characteristics, either in outbred or inbred populations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452789      PMCID: PMC1454804     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Relative distribution of various antigenic determinants on the human growth hormone surface.

Authors:  N Vita; M Etcheverrigaray; P L Biscayart; L A Retegui
Journal:  Mol Immunol       Date:  1986-06       Impact factor: 4.407

2.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

3.  Single lymph node cells producing heteroclitic bacteriophage antibody.

Authors:  O Mäkelä
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

4.  The recognition by monoclonal antibodies of various portions of a major antigenic site of human growth hormone.

Authors:  L A Retegui; R W Milne; C L Cambiaso; P L Masson
Journal:  Mol Immunol       Date:  1982-07       Impact factor: 4.407

5.  A relevant antigenic site in human growth hormone localized in sequence 98-128.

Authors:  C Peña; E Poskus; A C Paladini
Journal:  Mol Immunol       Date:  1980-12       Impact factor: 4.407

6.  Enhancing antibody: a novel component of the immune response.

Authors:  D A Nemazee; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Carrier-priming leads to hapten-specific suppression.

Authors:  L A Herzenberg; T Tokuhisa; L A Herzenberg
Journal:  Nature       Date:  1980-06-26       Impact factor: 49.962

8.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

9.  Human, bovine, and equine growth hormone antibodies in patients treated with human growth hormone.

Authors:  E Poskus; C Peña; A R Pérez; N Vita; J J Heinrich; A C Paladini
Journal:  J Clin Endocrinol Metab       Date:  1982-07       Impact factor: 5.958

10.  Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memory.

Authors:  L A Herzenberg; T Tokuhisa; D R Parks; L A Herzenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  2 in total

1.  Allosteric effects of monoclonal antibodies on human growth hormone.

Authors:  R C Aguilar; L A Retegui; M C Postel-Vinay; L P Roguin
Journal:  Mol Cell Biochem       Date:  1994-07-13       Impact factor: 3.396

2.  Monoclonal antibodies to human growth hormone induce an allosteric conformational change in the antigen.

Authors:  M M Mazza; L A Retegui
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.